Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Utility of RT-PCR Testing on Whole Blood for the Diagnosis of Early Lyme Disease

Title of conference presentation

AACC 2021: American Association for Clinical Chemistry
Sep 26-Sep 30, 2021, Atlanta, GA

Utility of RT-PCR Testing on Whole Blood for the Diagnosis of Early Lyme Disease

Authors: G Pratt, M Platt, A Velez, LV Rao

Specialties: infectious disease

Related content

Publication
A Comparison of Lyme Serological Testing Platforms with a Panel of Clinically Characterized Samples from Various Stages of Lyme Disease
Test FAQ
Lyme Disease Testing
On-Demand Webinar
Tick-borne Illness A Panel Discussion About Emerging Diagnostics Insights
Conference Presentation
Tick-Borne Disease Molecular Testing Positivity and Coinfection Incidence in the Northeastern United States: 2021-2023

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.